Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
81.1M
-
Shares change
-
-703K
-
Total reported value, excl. options
-
$2.48B
-
Value change
-
-$38.6M
-
Put/Call ratio
-
3.34
-
Number of buys
-
125
-
Number of sells
-
-106
-
Price
-
$30.60
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2016
290 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q2 2016.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.1M shares
of 93.1M outstanding shares and own 87.1% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (11.3M shares), Capital Research Global Investors (7.48M shares), VANGUARD GROUP INC (5.2M shares), SCOPIA CAPITAL MANAGEMENT LP (4.65M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (3.22M shares), D. E. Shaw & Co., Inc. (2.9M shares), BlackRock Fund Advisors (2.66M shares), STATE STREET CORP (2.16M shares), BlackRock Institutional Trust Company, N.A. (1.83M shares), and FRONTIER CAPITAL MANAGEMENT CO LLC (1.83M shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.